tradingkey.logo

Ocugen Gets EMA Backing on OCU410ST Approval Pathway for Stargardt Gene Therapy

ReutersAug 13, 2025 11:35 AM

- Ocugen Inc OCGN.O:

  • OCUGEN, INC. ANNOUNCES POSITIVE SCIENTIFIC ADVICE FROM THE EUROPEAN MEDICINES AGENCY RELATED TO THE APPROVAL PATHWAY FOR OCU410ST—MODIFIER GENE THERAPY FOR STARGARDT DISEASE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI